Skip to main content

Co-Diagnostics, Inc.

CODX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001692415

No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Co-Diagnostics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of CODX: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders1424+10
Shares49.2K595.8K+546.6K (+1,110.8%)
Value$91.5K$1.85M+$1.76M (+1,919.0%)

New holders (12)

Institutions that held Co-Diagnostics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to CODX in Q2 2026
InstitutionSharesValue% of portfolio
Armistice Capital, LLC236,000$731.6K0.02%
Jane Street Group, LLC89,240$276.6K0.00%
Vanguard Capital Management LLC58,275$180.7K0.00%
Millennium Management LLC31,995$99.2K0.00%
Susquehanna International Group, LLP31,239$96.8K0.00%
Geode Capital Management, LLC25,575$79.3K0.00%
Virtu Financial LLC17,612$55.0K0.00%
State Street Corp14,800$45.9K0.00%
Renaissance Technologies LLC12,500$38.8K0.00%
Global Retirement Partners, LLC100$3100.00%
FMR LLC7$210.00%
Northwestern Mutual Wealth Management Co1$30.00%

Sold out (2)

Institutions that held Co-Diagnostics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of CODX in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Danske Bank A/S7$13
Citigroup Inc1$2